Geode Capital Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.7M Buy
3,898,413
+177,090
+5% +$1.61M ﹤0.01% 1744
2025
Q4
$25M Sell
3,721,323
-70,741
-2% -$533K ﹤0.01% 1887
2025
Q3
$32.9M Buy
3,792,064
+23,711
+0.6% +$185K ﹤0.01% 1734
2025
Q2
$23.7M Buy
3,768,353
+4,345
+0.1% +$28.8K ﹤0.01% 1870
2025
Q1
$24.1M Buy
3,764,008
+106,313
+3% +$879K ﹤0.01% 1801
2024
Q4
$29.4M Buy
3,657,695
+155,206
+4% +$1.5M ﹤0.01% 1745
2024
Q3
$44.2M Buy
3,502,489
+304,159
+10% +$3.93M ﹤0.01% 1502
2024
Q2
$40.5M Buy
3,198,330
+610,596
+24% +$6.14M ﹤0.01% 1500
2024
Q1
$12.4M Buy
2,587,734
+290,227
+13% +$1.35M ﹤0.01% 2195
2023
Q4
$11M Buy
2,297,507
+436,530
+23% +$2.67M ﹤0.01% 2287
2023
Q3
$13.5M Buy
1,860,977
+117,971
+7% +$943K ﹤0.01% 2071
2023
Q2
$13M Buy
1,743,006
+490,352
+39% +$3.86M ﹤0.01% 2133
2023
Q1
$8.68M Buy
1,252,654
+155,675
+14% +$1.43M ﹤0.01% 2343
2022
Q4
$11.3M Buy
1,096,979
+55,747
+5% +$984K ﹤0.01% 2189
2022
Q3
$18.9M Buy
1,041,232
+18,636
+2% +$808K ﹤0.01% 1771
2022
Q2
$52.6M Buy
1,022,596
+23,197
+2% +$1.2M 0.01% 1081
2022
Q1
$73.5M Buy
999,399
+16,229
+2% +$1.45M 0.01% 964
2021
Q4
$141M Buy
983,170
+26,255
+3% +$4.51M 0.02% 666
2021
Q3
$198M Buy
956,915
+74,187
+8% +$16.4M 0.03% 531
2021
Q2
$187M Sell
882,728
-225,279
-20% -$41.3M 0.03% 555
2021
Q1
$201M Buy
1,108,007
+149,698
+16% +$29.8M 0.03% 499
2020
Q4
$107M Buy
958,309
+59,293
+7% +$6.3M 0.02% 664
2020
Q3
$97.4M Sell
899,016
-659
-0.1% -$80.3K 0.02% 613
2020
Q2
$75M Buy
899,675
+283,572
+46% +$10.8M 0.02% 678
2020
Q1
$8.37M Buy
616,103
+243,035
+65% +$2.06M ﹤0.01% 1845
2019
Q4
$1.48M Buy
373,068
+10,874
+3% +$47.2K ﹤0.01% 3132
2019
Q3
$1.82M Buy
362,194
+19,476
+6% +$107K ﹤0.01% 2994
2019
Q2
$2.01M Buy
342,718
+64,520
+23% +$508K ﹤0.01% 2950
2019
Q1
$3.06M Buy
278,198
+22,892
+9% +$723K ﹤0.01% 2594
2018
Q4
$9.39M Buy
255,306
+22,608
+10% +$876K ﹤0.01% 1822
2018
Q3
$8.75M Buy
232,698
+35,005
+18% +$986K ﹤0.01% 2028
2018
Q2
$5.3M Buy
197,693
+46,698
+31% +$1.58M ﹤0.01% 2289
2018
Q1
$6.34M Buy
150,995
+3,709
+3% +$149K ﹤0.01% 2088
2017
Q4
$3.65M Buy
147,286
+22,316
+18% +$544K ﹤0.01% 2401
2017
Q3
$2.85M Sell
124,970
-3,347
-3% -$74.9K ﹤0.01% 2549
2017
Q2
$2.95M Buy
128,317
+8,269
+7% +$162K ﹤0.01% 2505
2017
Q1
$3.07M Buy
120,048
+18,565
+18% +$511K ﹤0.01% 2404
2016
Q4
$2.56M Buy
101,483
+3,005
+3% +$87.6K ﹤0.01% 2496
2016
Q3
$4.1M Sell
98,478
-3,285
-3% -$424K ﹤0.01% 2093
2016
Q2
$14.8M Buy
101,763
+6,155
+6% +$705K 0.01% 1150
2016
Q1
$9.87K Buy
95,608
+4,814
+5% +$516K 0.01% 1414
2015
Q4
$15.2M Buy
90,794
+2,350
+3% +$362K 0.01% 1073
2015
Q3
$12.5M Buy
88,444
+1,845
+2% +$414K 0.01% 1172
2015
Q2
$19.3M Buy
86,599
+11,282
+15% +$1.98M 0.01% 955
2015
Q1
$12.5M Buy
75,317
+6,993
+10% +$1.14M 0.01% 1215
2014
Q4
$8.1M Buy
68,324
+1,754
+3% +$183K ﹤0.01% 1496
2014
Q3
$5.55M Sell
66,570
-5,556
-8% -$502K ﹤0.01% 1698
2014
Q2
$6.66M Buy
72,126
+20,290
+39% +$1.78M ﹤0.01% 1602
2014
Q1
$4.7M Buy
51,836
+5,893
+13% +$658K ﹤0.01% 1818
2013
Q4
$4.7M Buy
45,943
+12,620
+38% +$892K ﹤0.01% 1753
2013
Q3
$2.11M Buy
33,323
+3,703
+13% +$209K ﹤0.01% 2137
2013
Q2
$1.21M Buy
+29,620
New +$1.28M ﹤0.01% 2353

Other funds holding NVAX

Geode Capital Management's NVAX Position: Q1 2026 in Review

Geode Capital Management increased its Novavax (NVAX) stake by 4.8% in Q1 2026, buying an estimated $1.61M and bringing the position to 3,898,413 shares worth $31.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Geode Capital Management first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $201M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Geode Capital Management held 3,898,413 shares of Novavax worth $31.7M as of Q1 2026.
  • Geode Capital Management bought 177,090 Novavax shares in Q1 2026, an estimated $1.61M.
  • Novavax made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1744 holding.
  • Geode Capital Management first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Novavax position peaked at $201M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.